当前位置：
X-MOL 学术
›
Aliment. Pharm. Ther.
›
论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Prevalence of at-risk MASH, MetALD and alcohol-associated steatotic liver disease in the general population
Alimentary Pharmacology & Therapeutics ( IF 7.6 ) Pub Date : 2024-03-19 , DOI: 10.1111/apt.17958 Carolin V. Schneider 1 , Kai Markus Schneider 1 , Anastasia Raptis 1 , Helen Huang 1 , Christian Trautwein 1 , Rohit Loomba 2
Alimentary Pharmacology & Therapeutics ( IF 7.6 ) Pub Date : 2024-03-19 , DOI: 10.1111/apt.17958 Carolin V. Schneider 1 , Kai Markus Schneider 1 , Anastasia Raptis 1 , Helen Huang 1 , Christian Trautwein 1 , Rohit Loomba 2
Affiliation
|
The prevalence of at-risk metabolic dysfunction-associated steatohepatitis (at-risk MASH) has not been systematically assessed.
中文翻译：
一般人群中高危 MASH、MetALD 和酒精相关脂肪肝病的患病率
尚未对高危代谢功能障碍相关脂肪性肝炎（高危 MASH）的患病率进行系统评估。
更新日期：2024-03-19
中文翻译：
一般人群中高危 MASH、MetALD 和酒精相关脂肪肝病的患病率
尚未对高危代谢功能障碍相关脂肪性肝炎（高危 MASH）的患病率进行系统评估。
京公网安备 11010802027423号